The First Russian consensus on the quantitative assessment of the adherence to treatment (Approved by the XII National Congress of physicians - Moscow, 22–24 November 2017)


DOI: https://dx.doi.org/10.18565/therapy.2018.5.11-32

Nikolaj A. Nikolaev, Anatolij I. Martynov, Oksana M. Drapkina, Mariya A. Livzan, Sergej V. Moiseev, YUliya P. Skirdenko, Svetlana S. Bunova, Inna A. Viktorova, Vladimir S. Zadionchenko, Leonid B. Lazebnik, Andrej G. Malyavin, Anastasiya V. Nelidova, Galina I. Nechaeva, Liliya A. Pushkaryova, Andrej P. Rebrov, Rustam I. Sajfutdinov, Valerij I. Sovalkin, Vladimir P. Terent’ev, Vladimir P. Tyurin, Vitalij P. Urazov, Gleb B. Fedoseev, Aleksandr V. YAgoda, Sergej S. YAkushin, Leonid N. YAsnickij

1 Federal state budgetary educational institution of higher education «Omsk state medical University» of Ministry of health of the Russian Federation; 2 Federal state budgetary educational institution of higher professional education «Moscow state medical dental University. A.I. Evdokimov» of the Ministry of health of the Russian Federation; 3 National medical research center of preventive medicine of the Ministry of health of Russia; 4 Federal state Autonomous educational institution of higher education «First Moscow state medical University I.M. Sechenov» Ministry of health of the Russian Federation (Sechenovskiy University); 5 «Family doctor, LLC», Moscow; 6 Luxoft Professional, LLC, Moscow; 7 Federal state budgetary educational institution of higher professional education «Saratov state medical University named after V.I. Razumovsky» Ministry of health of the Russian Federation; 8 Federal state budgetary educational institution of higher education «Orenburg state medical University» of Ministry of health of the Russian Federation; 9 Federal state budgetary educational institution of higher professional education «Rostov state medical University» Ministry of healthcare of the Russian Federation; 10 Federal state budgetary institution «Nnational medical surgical Center to them. N. And. Pirogov» Ministry of health of the Russian Federation; 11 Custom software development company «Information Service Systems Art, LLC»; 12 Federal state budgetary educational institution of higher education «First St. Petersburg state medical University academician I.P. Pavlov» of the Ministry of health of the Russian Federation; 13 Federal state budgetary educational institution of higher professional education «Stavropol state medical University» Ministry of healthcare of the Russian Federation; 14 Federal state budgetary educational institution of higher professional education «Ryazan state medical University academician I. Р. Pavlov» of the Ministry of health of the Russian Federation; 15 Federal state budgetary educational institution of higher professional education «Perm state national research University»; 16 Federal state Autonomous educational institution of higher education «National research University „Higher school of Economics“».
The first Russian Consensus on the quantitative assessment of the adherence to treatment approved by the XII National Congress of physicians (Moscow, 22–24 November 2017)
Keywords: adherence to treatment, quantitative assessment, recommendations, Russian consensus
Read entire article

Literature

  • Драпкина О.М., Ливзан М.А. Мартынов А.И., Моисеев С.В., Николаев Н.А. , Скирденко Ю.П. и др. Первый Российский консенсус по количественной оценке приверженности к лечению: основные положения, алгоритмы и рекомендации. Мед. вестник Северного Кавказа. 2018; 13(1.2): 259–271.
  • Николаев Н.А. , Скирденко Ю.П. Российский универсальный опросник количественной оценки приверженности к лечению (КОП-25). Клиническая фармакология и терапия. 2018; 27(1): 74–8.
  • Николаев Н.А. Доказательная гипертензиология: пациентоориентированная антигипертензивная терапия. М., 2015.
  • Николаев Н.А. Количественная оценка приверженности к лечению в клинической медицине: протокол, процедура, интерпретация. Качеств. клинич. практика. 2016; 1: 50–9.
  • Николаев Н.А. Руководство по клиническим исследованиям внутренних болезней. М., 2015.
  • Фофанова Т.В. Приверженность к терапии и методы ее повышения у больных артериальной гипертонией и ишемической болезнью сердца. Дисс. док. мед. наук. М., 2015.
  • Чукаева И.И. Что такое приверженность к лечению и что можно сделать для ее улучшения (на примере артериальной гипертонии). Лечебное дело. 2012; 2: 21–6.
  • Atkinson M.J., Sinha A., Hass S.L. et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual. Life Outcomes. 2004; 2: 12.
  • Benner J.S., Tierce J.C., Ballantyne C.M. et al. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics. 2004; 22 (Suppl. 3):13–23.
  • Brown M.J. Resistant hypertension: resistance to treatment or resistance to taking treatment? Heart. 2014; 100(11): 821–2.
  • Burnier M. Managing ‘resistance’: is adherence a target for treatment? Curr. Opin. Nephrol. Hypertens. 2014; 23(5): 439–43.
  • DiMatteo M.R., Giodani P.J., Lepper Y.S., Croghan T.W. Patient adherence and medical treatment out comes: a meta-analysis. Med.Care. 2002; 40(9): 794–811.
  • Garcia A., Leiva F., Martos F., Garcia A., Prados D., Sanchez F. How to diagnose adherence to treatment in primary health care? Medicina de Familia. 2000; 1: 13–9.
  • Haynes R.B., McDonald H., Garg A.X., Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst. Rev. 2002; CD000011.
  • Horne R., Weinman J., Barber N., Elliot R., Morgan M. Concordance, adherence and compliane in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D. 2005.
  • Intas G., Kalogianni A., Stergiannis P., Bratakos M. et al. Development and validation of a diabetes self-care activities questionnaire. J. Diab. Nursing. 2012; 16(3): 100–10.
  • Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care. 1986; 24: 67–74.
  • Morisky D.E., Ang A., Krousel-Wood M., Ward H. J. Predictive validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens (Greenwich). 2008; 10(5): 348–54.
  • Munger M.A., Van Tassell B.W., LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. Med. Gen. Med. 2007; 9(3): 58.
  • Osterberg L., Blaschke T. Adherence to medication. N. Engl. J. Med. 2005; 353(5): 487–97.
  • Pérez-Escamilla B., Franco-Trigo L., Moullin J.C. et al. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer. Adherence. 2015; 9: 569–78.
  • Skovlund S.E. Patient-reported Assessments in Diabetes Care: Clinical and Research Applications. Curr. Diab. Rep. 2005; 5: 115–23.
  • The ISPOR Compliance and Persistence SIG Definitions Working Group. www.ispor.org/sigs/medication.asp.
  • Wilke T., Müller S. Nonadherence in Outpatient Thromboprophylaxis after Major Orthopedic Surgery: A Systematic Review. Expert. Rev. Pharmacoeconomics Outcomes Res. 2010; 10(6): 691–700.
  • 2World Health Organization: Adherence to long-term therapies: evidence for action. 2003. http://www.who.int/ chp/knowledge/publications/adherence_full_report.pdf.
  • World Health Organization. Secondary prevention of non-communicable disease in low and middle-income countries through community-based and health service interventions. 2002. http://www.who.int/ chp/knowledge /publications/adherence_full_report.pdf.

    • Back to Content

    Бионика Медиа